BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8453437)

  • 1. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride.
    Stacher G; Abatzi-Wenzel TA; Wiesnagrotzki S; Bergmann H; Schneider C; Gaupmann G
    Br J Psychiatry; 1993 Mar; 162():398-402. PubMed ID: 8453437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of cisapride in anorexia nervosa.
    Szmukler GI; Young GP; Miller G; Lichtenstein M; Binns DS
    Int J Eat Disord; 1995 May; 17(4):347-57. PubMed ID: 7620474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.
    Stacher G; Bergmann H; Wiesnagrotzki S; Kiss A; Schneider C; Mittelbach G; Gaupmann G; Höbart J
    Gastroenterology; 1987 Apr; 92(4):1000-6. PubMed ID: 3556983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric emptying and bloating in anorexia nervosa.
    Lee S
    Br J Psychiatry; 1993 Jul; 163():128-9. PubMed ID: 8353690
    [No Abstract]   [Full Text] [Related]  

  • 5. Slow gastric emptying induced by high fat content of meal accelerated by cisapride administered rectally.
    Stacher G; Granser GV; Bergmann H; Kugi A; Stacher-Janotta G; Höbart J
    Dig Dis Sci; 1991 Sep; 36(9):1259-65. PubMed ID: 1893810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different dosage schedules of cisapride on gastric emptying in idiopathic gastroparesis.
    Corinaldesi R; Stanghellini V; Tosetti C; Rea E; Corbelli C; Marengo M; Monetti N; Barbara L
    Eur J Clin Pharmacol; 1993; 44(5):429-32. PubMed ID: 8359178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.
    Abell TL; Camilleri M; DiMagno EP; Hench VS; Zinsmeister AR; Malagelada JR
    Dig Dis Sci; 1991 May; 36(5):616-20. PubMed ID: 2022163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients.
    Tatsuta M; Iishi H; Nakaizumi A; Okuda S
    Aliment Pharmacol Ther; 1992 Apr; 6(2):221-8. PubMed ID: 1600042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.
    Jian R; Ducrot F; Ruskone A; Chaussade S; Rambaud JC; Modigliani R; Rain JD; Bernier JJ
    Dig Dis Sci; 1989 May; 34(5):657-64. PubMed ID: 2653742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a single rectal dose of cisapride on delayed gastric emptying.
    Brummer RJ; Schoenmakers EA; Kemerink GJ; Heidendal GA; Sanders DG; Stockbrügger RW
    Aliment Pharmacol Ther; 1997 Aug; 11(4):781-5. PubMed ID: 9305489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa.
    Stacher G; Peeters TL; Bergmann H; Wiesnagrotzki S; Schneider C; Granser-Vacariu GV; Gaupmann G; Kugi A
    Gut; 1993 Feb; 34(2):166-72. PubMed ID: 8432466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride and gastric emptying of a solid meal in dyspeptic diabetics without autonomic neuropathy and in healthy volunteers.
    Brogna A; Ferrara R; Scornavacca G; Lombardo A; Bucceri A; Catalano F; Paradisi V; Onorato S
    Eur J Clin Pharmacol; 1989; 37(4):411-3. PubMed ID: 2598976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis.
    Richards RD; Valenzuela GA; Davenport KG; Fisher KL; McCallum RW
    Dig Dis Sci; 1993 May; 38(5):811-6. PubMed ID: 8482178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cisapride on antroduodenal co-ordination and gastric emptying.
    Johnson AG
    Scand J Gastroenterol Suppl; 1989; 165():36-43. PubMed ID: 2690323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo.
    Feldman M; Smith HJ
    Gastroenterology; 1987 Jan; 92(1):171-4. PubMed ID: 3781184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial.
    Di Lorenzo C; Reddy SN; Villanueva-Meyer J; Mena I; Martin S; Hyman PE
    Gastroenterology; 1991 Dec; 101(6):1564-70. PubMed ID: 1955122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride.
    Champion MC
    Scand J Gastroenterol Suppl; 1989; 165():44-52; discussion 52-3. PubMed ID: 2690324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
    Maddern GJ; Jamieson GG; Myers JC; Collins PJ
    Gut; 1991 May; 32(5):470-4. PubMed ID: 2040466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous noninvasive evaluation of gastric emptying and orocaecal transit times. Use in studying the actions of cisapride in diabetic patients.
    Bergmann JF; Chassany O; Guillausseau PJ; Bayle M; Chagnon S; Caulin C; Sallenave JR
    Eur J Clin Pharmacol; 1992; 43(2):121-4. PubMed ID: 1425866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cisapride on gastric emptying of oil and aqueous meal components, hunger, and fullness.
    Jones KL; Horowitz M; Carney BI; Sun WM; Chatterton BE
    Gut; 1996 Mar; 38(3):310-5. PubMed ID: 8675080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.